(株)ペルセウスプロテオミクスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4882/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/04/01 | 日証協 | 837,659株 | -1.54% | 62,541株 | -70.88% | 872,403株 | -1.16% | 87,602株 | -53.75% |
2022/03/25 | 日証協 | 850,759株 | +5.51% | 214,800株 | +488.49% | 882,603株 | +10.24% | 189,425株 | +571.7% |
2022/03/18 | 日証協 | 806,359株 | +0.77% | 36,500株 | -5.19% | 800,604株 | -0.71% | 28,201株 | -33.01% |
2022/03/11 | 日証協 | 800,159株 | -5.14% | 38,500株 | -91.48% | 806,304株 | -0.67% | 42,100株 | -61.59% |
2022/03/04 | 日証協 | 843,559株 | +3.36% | 451,800株 | -32.04% | 811,704株 | -6.49% | 109,601株 | -74.46% |
2022/02/25 | 日証協 | 816,118株 | +33.86% | 664,759株 | +167.29% | 868,064株 | +27.74% | 429,100株 | +135.05% |
2022/02/18 | 日証協 | 609,659株 | +22.58% | 248,700株 | -45.57% | 679,564株 | +15.34% | 182,560株 | -33.25% |
2022/02/10 | 日証協 | 497,359株 | +32.45% | 456,889株 | -15.08% | 589,204株 | +11.48% | 273,502株 | -32.34% |
2022/02/04 | 日証協 | 375,511株 | +682.14% | 538,000株 | +9999.99% | 528,544株 | +92.53% | 404,223株 | +4293.73% |
2022/01/28 | 日証協 | 48,011株 | -3.23% | 2,400株 | +9.09% | 274,522株 | -1.22% | 9,200株 | +21.05% |
2022/01/21 | 日証協 | 49,611株 | -2.36% | 2,200株 | -88.6% | 277,922株 | +1.05% | 7,600株 | -49.34% |
2022/01/14 | 日証協 | 50,811株 | +8.08% | 19,300株 | +704.17% | 275,022株 | +1.48% | 15,001株 | -53.3% |
2022/01/07 | 日証協 | 47,011株 | +0.43% | 2,400株 | -64.18% | 271,021株 | +15.86% | 32,120株 | +234.58% |
2021/12/30 | 日証協 | 46,811株 | 0% | 6,700株 | 0% | 233,921株 | 0% | 9,600株 | 0% |
2021/12/24 | 日証協 | 46,811株 | -6.59% | 6,700株 | -12.99% | 233,921株 | -0.72% | 9,600株 | +18.52% |
2021/12/17 | 日証協 | 50,111株 | -35.68% | 7,700株 | +54% | 235,621株 | -8.75% | 8,100株 | -44.96% |
2021/12/10 | 日証協 | 77,911株 | +0.52% | 5,000株 | -48.98% | 258,205株 | +1.89% | 14,716株 | +21.62% |
2021/12/03 | 日証協 | 77,511株 | 0% | 9,800株 | -13.27% | 253,405株 | -0.16% | 12,100株 | +210.26% |
2021/11/26 | 日証協 | 77,511株 | +1.04% | 11,300株 | -24.67% | 253,805株 | +1.56% | 3,900株 | -72.56% |
※株式分割は考慮していませんのでご注意ください。
Page Top